Eur Rev Med Pharmacol Sci 2021; 25 (2): 567-567
DOI: 10.26355/eurrev_202101_24593

Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2

W. Wang, M.-L. Dong, W. Zhang, T. Liu

Department of Pharmacy, Yantai Yuhuangding Hospital, Yantai, China.

 


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2, by W. Wang, M.-L. Dong, W. Zhang, T. Liu, published in Eur Rev Med Pharmacol Sci 2019; 23 (12): 5229-5234–DOI: 10.26355/eurrev_201906_18188–PMID: 31298373” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/18188

Free PDF Download

To cite this article

W. Wang, M.-L. Dong, W. Zhang, T. Liu
Long noncoding LUCAT1 promotes cisplatin resistance of non-small cell lung cancer by promoting IGF-2

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 2
Pages: 567-567
DOI: 10.26355/eurrev_202101_24593